Cognition Days Of Inventory Outstanding from 2010 to 2024

CGTX Stock  USD 0.45  0.03  7.14%   
Cognition Therapeutics Days Of Inventory Outstanding yearly trend continues to be fairly stable with very little volatility. Days Of Inventory Outstanding is likely to outpace its year average in 2024. During the period from 2010 to 2024, Cognition Therapeutics Days Of Inventory Outstanding regression line of annual values had r-squared of  0.63 and arithmetic mean of  2,493. View All Fundamentals
 
Days Of Inventory Outstanding  
First Reported
2010-12-31
Previous Quarter
K
Current Value
7.4 K
Quarterly Volatility
3.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cognition Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cognition Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 91.2 K, Selling General Administrative of 9.8 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.38. Cognition financial statements analysis is a perfect complement when working with Cognition Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Cognition Therapeutics Correlation against competitors.
For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.

Latest Cognition Therapeutics' Days Of Inventory Outstanding Growth Pattern

Below is the plot of the Days Of Inventory Outstanding of Cognition Therapeutics over the last few years. It is Cognition Therapeutics' Days Of Inventory Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cognition Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Days Of Inventory Outstanding10 Years Trend
Slightly volatile
   Days Of Inventory Outstanding   
       Timeline  

Cognition Days Of Inventory Outstanding Regression Statistics

Arithmetic Mean2,493
Geometric Mean1,171
Coefficient Of Variation127.08
Mean Deviation2,683
Median527.22
Standard Deviation3,168
Sample Variance10M
Range7.3K
R-Value0.79
Mean Square Error4M
R-Squared0.63
Significance0.0004
Slope562.00
Total Sum of Squares140.5M

Cognition Days Of Inventory Outstanding History

2024 7395.49
2023 7043.32
2021 7825.91
2020 2026.12

About Cognition Therapeutics Financial Statements

Cognition Therapeutics investors use historical fundamental indicators, such as Cognition Therapeutics' Days Of Inventory Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cognition Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory OutstandingK7.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cognition Stock Analysis

When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.